000 01723 a2200481 4500
005 20250516084829.0
264 0 _c20120803
008 201208s 0 0 eng d
022 _a1029-2330
024 7 _a10.3109/1061186X.2012.656645
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBriane, Dominique
245 0 0 _aInhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
_h[electronic resource]
260 _bJournal of drug targeting
_cMay 2012
300 _a347-54 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCations
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCholesterol
_xanalogs & derivatives
650 0 4 _aDNA
_xadministration & dosage
650 0 4 _aDrug Carriers
_xchemical synthesis
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFlow Cytometry
650 0 4 _aGene Silencing
650 0 4 _aGreen Fluorescent Proteins
_xgenetics
650 0 4 _aHumans
650 0 4 _aLiposomes
650 0 4 _aPlasmids
650 0 4 _aRNA, Small Interfering
_xadministration & dosage
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aTransfection
650 0 4 _aVascular Endothelial Growth Factor A
_xgenetics
700 1 _aSlimani, Hocine
700 1 _aTagounits, Arezki
700 1 _aNaejus, Regine
700 1 _aHaddad, Oualid
700 1 _aCoudert, Robert
700 1 _aCharnaux, Nathalie
700 1 _aCao, An
773 0 _tJournal of drug targeting
_gvol. 20
_gno. 4
_gp. 347-54
856 4 0 _uhttps://doi.org/10.3109/1061186X.2012.656645
_zAvailable from publisher's website
999 _c21677468
_d21677468